Loss-of-function mutation of ANGPTL3 has been found to relate to lower levels of both triglycerides and LDL-C, as well as a 41% lower risk of CHD (Dewey et al., 2017). The gene discussed is ANGPTL3; the disease is coronary artery disorder.